Research ArticleArticle
Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1
Emi Kimoto, Manoli Vourvahis, Renato J. Scialis, Heather Eng, A. David Rodrigues and Manthena V. S. Varma
Drug Metabolism and Disposition March 12, 2019, dmd.118.085241; DOI: https://doi.org/10.1124/dmd.118.085241
Emi Kimoto
1 Pfizer Inc.;
Manoli Vourvahis
1 Pfizer Inc.;
Renato J. Scialis
2 Bristol-Myers Squibb
Heather Eng
1 Pfizer Inc.;
A. David Rodrigues
1 Pfizer Inc.;
Manthena V. S. Varma
1 Pfizer Inc.;
Article Figures & Data
Additional Files
Data Supplement
- Supplemental Data -
Supplemental methods and 3 figures.
- Supplemental Data -
In this issue
Research ArticleArticle
Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1
Emi Kimoto, Manoli Vourvahis, Renato J. Scialis, Heather Eng, A. David Rodrigues and Manthena V. S. Varma
Drug Metabolism and Disposition March 12, 2019, dmd.118.085241; DOI: https://doi.org/10.1124/dmd.118.085241
Research ArticleArticle
Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1
Emi Kimoto, Manoli Vourvahis, Renato J. Scialis, Heather Eng, A. David Rodrigues and Manthena V. S. Varma
Drug Metabolism and Disposition March 12, 2019, dmd.118.085241; DOI: https://doi.org/10.1124/dmd.118.085241
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement